
Danaher Corporation DHR
€ 148.21
0.21%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation Kurshistorie 2011-2026 | DHR
Kurshistorie Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 | 208 | 249 | 250 | 274 | 219 | 143 | 125 | 95.9 | 83.3 | 44.7 | 43.3 | 37.8 | 30.4 | 26 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 274 | 26 | 136 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
Fulgent Genetics
FLGT
|
17.1 | $ 17.54 | 2.51 % | $ 540 M | ||
|
Guardant Health
GH
|
107 | $ 119.6 | 0.55 % | $ 15 B | ||
|
Agilent Technologies
A
|
139 | $ 115.32 | 0.31 % | $ 35.1 B | ||
|
Celcuity
CELC
|
115 | $ 135.32 | -2.11 % | $ 6.33 B | ||
|
Akumin
AKU
|
0.84 | - | -17.87 % | $ 25.9 M | ||
|
Illumina
ILMN
|
103 | $ 145.78 | 0.95 % | $ 23.2 B | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 7.04 | 38.83 % | $ 9.36 M | ||
|
Castle Biosciences
CSTL
|
16.3 | $ 19.68 | -2.33 % | $ 570 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 21.8 | 0.79 % | $ 1.16 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 1.8 | -1.1 % | $ 7.96 M | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 100.3 | -2.62 % | $ 6.77 B | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 114.32 | -2.11 % | $ 9.43 B | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 100.85 | -0.2 % | $ 22.7 B | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 9.22 | -0.11 % | $ 1.18 B | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
National Research Corporation
NRC
|
14.1 | $ 18.99 | -0.47 % | $ 425 M | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Natera
NTRA
|
53.9 | $ 203.42 | 0.11 % | $ 20 B | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 156.53 | -2.35 % | $ 7.76 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Medpace Holdings
MEDP
|
449 | $ 426.76 | -1.4 % | $ 12.3 B | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 3.78 | -1.18 % | $ 350 M | ||
|
Personalis
PSNL
|
4.83 | $ 9.02 | 6.49 % | $ 805 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 26.87 | -0.3 % | $ 25.5 B | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 6.47 | 1.97 % | $ 270 M | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
41 | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
3.13 | $ 2.44 | -1.81 % | $ 5.6 M | ||
|
Twist Bioscience Corporation
TWST
|
26.1 | $ 64.81 | 7.0 % | $ 3.88 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 259.66 | -0.1 % | $ 21.6 B | ||
|
Thermo Fisher Scientific
TMO
|
520 | $ 449.1 | 0.18 % | $ 169 B | ||
|
Trinity Biotech plc
TRIB
|
0.54 | $ 0.64 | 6.3 % | $ 230 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
330 | $ 341.01 | -0.4 % | $ 20.3 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 8.97 | 0.73 % | $ 1.95 B | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 193.85 | -0.7 % | $ 21.5 B |